Publications by authors named "Flavio Forrer"

Claim this Profile
E
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Moritz C Neubauer, Guillaume P Nicolas, Andreas Bauman, Melpomeni Fani, Egbert Nitzsche, Flavio Forrer

Eur J Nucl Med Mol Imaging· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, Michael S Hofman, Louise Emmett, Flavio Forrer

Eur J Nucl Med Mol Imaging· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Intraosseous hibernoma (IOH) mimics osseous metastasis: another rare pitfall in FDG-PET-CT.
Sebastian J Stolte, Hanna Geiger, Flavio Forrer, Regulo Rodriguez, Joachim Müller

Front Nucl Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.
Flavio Forrer, Galina Farina Fischer, Ole Maas, Luca Giovanella, Martha Hoffmann

Oncology· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 pandemic on nuclear medicine departments in Europe.
Ana Paula Moreira, François Jamar, Zehra Ozcan, Doina Piciu, Claudine Als, Flavio Forrer

Eur J Nucl Med Mol Imaging· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI.
Thomas Weikert, Ole Christopher Maas, Tanja Haas, Markus Klarhöfer, Jens Bremerich, Flavio Forrer

Contrast Media Mol Imaging· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma.
Shamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, Jun Wang, Sergio Cogliatti, Flavio Forrer

Haematologica· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT).
Clemens Kratochwil, Wolfgang Peter Fendler, Matthias Eiber, Richard Baum, Murat Fani Bozkurt, Flavio Forrer

Eur J Nucl Med Mol Imaging· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid neoplasms after chemotherapy and PRRT: myth and reality.
Lisa Bodei, Irvin M Modlin, Markus Luster, Flavio Forrer, Marta Cremonesi

Endocr Relat Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report.
Verena Schwetz, Karl Horvath, Patrizia Kump, Carolin Lackner, Aurel Perren, Flavio Forrer

Medicine (Baltimore)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas.
Karine Gerster-Gilliéron, Flavio Forrer, Helmut Maecke, Jan Mueller-Brand, Adrian Merlo

J Nucl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT/CT for the assessment of painful knee prosthesis.
Flavio Forrer, Michael T Hirschmann, Helmut F Rasch

Nucl Med Commun· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.
Emanuel Christ, Damian Wild, Susanne Ederer, Martin Béhé, Guillaume Nicolas, Flavio Forrer

Lancet Diabetes Endocrinol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4D-SPECT/CT in orthopaedics: a new method of combined quantitative volumetric 3D analysis of SPECT/CT tracer uptake and component position measurements in patients after total knee arthroplasty.
Helmut Rasch, Anna L Falkowski, Flavio Forrer, Johann Henckel, Michael T Hirschmann

Skeletal Radiol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.
Flavio Forrer, Catharina Oechslin-Oberholzer, Benedetta Campana, Richard Herrmann, Helmut R Maecke

J Nucl Med· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Gregor Sommer, Mark Wiese, Leopold Winter, Claudia Lenz, Markus Klarhöfer, Flavio Forrer

Eur Radiol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors.
Giampiero Giovacchini, Guillaume Nicolas, Flavio Forrer

Anticancer Agents Med Chem· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
Keelara Abiraj, Rosalba Mansi, Maria-Luisa Tamma, Melpomeni Fani, Flavio Forrer

J Nucl Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiopeptide imaging and therapy in Europe.
Valentina Ambrosini, Melpomeni Fani, Stefano Fanti, Flavio Forrer, Helmut R Maecke

J Nucl Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy.
Giampiero Giovacchini, Guillaume Nicolas, Heike Freidank, Thomas L Mindt, Flavio Forrer

Eur J Nucl Med Mol Imaging· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Francesco Giammarile, Lisa Bodei, Carlo Chiesa, Glenn Flux, Flavio Forrer

Eur J Nucl Med Mol Imaging· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
Damian Wild, Emanuel Christ, Martyn E Caplin, Tom R Kurzawinski, Flavio Forrer

J Nucl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted radiotherapy with radiolabeled somatostatin analogs.
Guillaume Nicolas, Giampiero Giovacchini, Jan Müller-Brand, Flavio Forrer

Endocrinol Metab Clin North Am· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours.
Rosalba Mansi, Xuejuan Wang, Flavio Forrer, Beatrice Waser, Renzo Cescato

Eur J Nucl Med Mol Imaging· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant targeting of glioblastoma multiforme with radiolabeled DOTAGA-substance P--results from a phase I study.
Dominik Cordier, Flavio Forrer, Stefan Kneifel, Martin Sailer, Luigi Mariani

J Neurooncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis